An immuno-enzymatic assay for herpes simplex virus tumour associated antigen in gynecological oncology.
The authors studied the HSV-TAA (Herpes Simplex Virus Tumor Associated Antigen) in patients affected by female genitale tract tumors, using the immunoenzymatic assay (ELISA). They found a positive frequence of 65% in sera of patients affected by uterine cervical carcinoma and of the 80% in sera of patients affected by vulvar carcinoma. The authors suggest that this enzymatic method has a real value and propose its use in the early diagnosis of the female genital tract neoplasms.
D000951:Antigens, Neoplasm / Q000032:analysis*; D000956:Antigens, Viral / Q000032:analysis*; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D018139:Simplexvirus / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000032:analysis* / Q000276:immunology; D014846:Vulvar Neoplasms / Q000032:analysis* / Q000276:immunology
D000951:Antigens, Neoplasm; D000956:Antigens, Viral